Mesa, Nefertilyn .
HRN: 29-10-10 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/04/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/04/2026
06/06/2026
IV
500
Q8 For 4 Doses
S/P LTCS
Checking Final Appropriateness
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes